Small island developing States (SIDS) vs Uruguay: Proportion of the target population who received a 3rd dose of
Small island developing States (SIDS)
53.0%
in 2024
Uruguay
96.0%
in 2024
Small island developing States (SIDS) rank
30th
Uruguay rank
16th
Proportion of the target population who received a 3rd dose of over time
- Small island developing States (SIDS)
- Uruguay
How they compare
Uruguay currently reports 96.0% against 53.0% in Small island developing States (SIDS), a difference of 43.0%.
That makes Uruguay's figure about 1.8 times Small island developing States (SIDS)'s.
Across all 15 years both countries report, Uruguay has been ahead every year.
Small island developing States (SIDS) ranks 30th and Uruguay ranks 16th of 37 groups.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Small island developing States (SIDS) | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.2% | 93.4% | 75.2% | Uruguay |
| 2020s | 49.0% | 94.4% | 45.4% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Small island developing States (SIDS) or Uruguay?
- Uruguay, at 96.0% against 53.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Small island developing States (SIDS) and Uruguay?
- 43.0%, with Uruguay ahead.
- How many years of comparable data are there for Small island developing States (SIDS) and Uruguay?
- 15 years are reported by both, from 2010 to 2024.
- How do Small island developing States (SIDS) and Uruguay rank globally for proportion of the target population who received a 3rd dose of?
- Small island developing States (SIDS) ranks 30th and Uruguay ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.